Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Glioblastoma Therapeutics Network (GTN; U19 Clinical Trial Required)

    This grant funds collaborative teams to develop and clinically test new or repurposed drugs that cross the blood-brain barrier to improve adult glioblastoma treatment.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Conquer Cancer - The Sontag Foundation Young Investigator Award in honor of the 10th Anniversary of The Brain Tumor Network

    Funds research on gene-edited NK cells and oncolytic viruses to enhance immunotherapy for glioblastoma by overcoming tumor-induced immune suppression.

    Sontag FoundationRolling submissions

    Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

    Funding opportunity for advancing nanotechnology-based cancer treatments to improve effectiveness through innovative nanoparticle designs and cargos.

    HHS-NIH11Due Nov 16, 2026· 21d

    Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

    This grant supports the continued operation of national biobanks for collecting, storing, and distributing cancer clinical trial biospecimens to advance translational cancer research.

    HHS-NIH11Due Feb 11, 2027$19,000,000

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

    Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.

    HHS-NIH11Due Feb 18, 2027

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.

    HHS-NIH11Due Dec 1, 2030$6,000,000